Clinical trial

Africa and Middle East Cardiovascular Epidemiological Study

NCT01243138

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2011-07-01

PhaseN/A

Study timeline

Study start (unknown)2011-07-01Date precision: month

Registry last updated2021-02-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Obesityunresolved

Smokingunresolved

Dyslipidemiaunresolved

Diabetes Mellitusunresolved

Hypertensionunresolved

Interventions

Sponsors & collaborators

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.lead sponsor

Mapped research locations

CairoEgypt1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01243138 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.